What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS?
Publication
, Journal Article
Shelley Hwang, E; Thompson, A
Published in: J Natl Cancer Inst
April 1, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Cancer Inst
DOI
EISSN
1460-2105
Publication Date
April 1, 2017
Volume
109
Issue
4
Location
United States
Related Subject Headings
- Transcriptome
- Radiotherapy, Conformal
- Prognosis
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Mastectomy, Segmental
- Incidence
- Humans
- Female
- Combined Modality Therapy
Citation
APA
Chicago
ICMJE
MLA
NLM
Shelley Hwang, E., & Thompson, A. (2017). What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS? J Natl Cancer Inst, 109(4). https://doi.org/10.1093/jnci/djw270
Shelley Hwang, E., and Alastair Thompson. “What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS?” J Natl Cancer Inst 109, no. 4 (April 1, 2017). https://doi.org/10.1093/jnci/djw270.
Shelley Hwang E, Thompson A. What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS? J Natl Cancer Inst. 2017 Apr 1;109(4).
Shelley Hwang, E., and Alastair Thompson. “What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS?” J Natl Cancer Inst, vol. 109, no. 4, Apr. 2017. Pubmed, doi:10.1093/jnci/djw270.
Shelley Hwang E, Thompson A. What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS? J Natl Cancer Inst. 2017 Apr 1;109(4).
Published In
J Natl Cancer Inst
DOI
EISSN
1460-2105
Publication Date
April 1, 2017
Volume
109
Issue
4
Location
United States
Related Subject Headings
- Transcriptome
- Radiotherapy, Conformal
- Prognosis
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Mastectomy, Segmental
- Incidence
- Humans
- Female
- Combined Modality Therapy